Richard I. Morimoto

Director, Rice Institute for Biomedical Research; Dean of Graduate School; John Evans Professor of Biology, Northwestern University

Treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s are changing, thanks to Richard I. Morimoto’s research on protein folding in the brain. A leader in the field, Morimoto serves as director of the Rice Institute for Biomedical Research and runs the Morimoto Laboratory at Northwestern University, where he has been a faculty member since 1982.

The researcher has also founded his own biotechnology company, Proteostasis Therapeutics, based in Cambridge, Mass. It is the first company dedicated to the discovery of new therapeutics based on understanding the body’s natural proteostasis network, creating new opportunities for treating neurodegenerative diseases.